Financial Data and Key Metrics Changes - For the full year 2025, the company generated $879.3 million in total revenues, an increase of 8.2% compared to the prior year [21] - Adjusted EBITDA for Q4 2025 was $59.8 million, up from $50.1 million in Q4 2024, while full-year Adjusted EBITDA decreased to $219.8 million from $239.8 million [23][24] - Adjusted Diluted EPS for Q4 and full year 2025 was $1.46 and $4.45, respectively, compared to $0.87 and $5.34 for the same periods in 2024 [24] Business Line Data and Key Metrics Changes - Applebee's full-year Comp Sales were +1.3%, recovering from -4.2% in 2024, while Q4 Comp Sales were -0.4% [8] - IHOP's full-year Comp Sales were -1.5%, an improvement from -2% in 2024, with Q4 Comp Sales at +0.3% [8] - Off-premise Comp Sales for Applebee's increased by 6.5% for the full year, while IHOP's off-premise sales contributed to a positive 4.5% Comp Sales increase in Q4 [10][13] Market Data and Key Metrics Changes - The casual and family dining categories experienced softening in Comp Sales and traffic in December 2025 [6] - Applebee's commodity costs in Q4 increased by 0.5%, while IHOP's commodity costs rose by 3.5% compared to the prior year [27] - The company expects commodity costs in 2026 to be mid-single digits for Applebee's and low single digits for IHOP, primarily driven by higher beef prices [28] Company Strategy and Development Direction - The company plans to continue focusing on enhancing guest experience, operational improvements, and menu innovation [4][7] - Dual-brand openings are seen as a key growth strategy, with expectations of at least 50 new dual-brand openings in 2026 [18] - The Applebee's Lookin' Good remodel program aims to remodel another 100 locations in 2026, building on positive early results [19] Management's Comments on Operating Environment and Future Outlook - Management noted that consumer behavior remains focused on value and overall guest experience, with a significant portion of sales driven by value offerings [46] - The company is optimistic about 2026, expecting continued positive trends in Comp Sales and traffic, despite challenges from severe weather [34] - The focus for 2026 includes disciplined execution, enhancing guest experience, and protecting margins through balanced menu offerings [15] Other Important Information - The company returned $92 million to shareholders in 2025 through buybacks and dividends, with a commitment to continue share repurchases [25] - The company operated 72 company-owned restaurants at the end of 2025, with plans to remodel approximately 23 restaurants and complete eight dual-brand conversions in 2026 [29][30] Q&A Session Summary Question: How did the fourth quarter compare to internal expectations? - Management acknowledged some temporary softening in December but noted that momentum has been building back up in Q1 despite winter storms [38][39] Question: What are the plans for share repurchases in 2026? - Management confirmed that they will continue the buyback program as long as the share price remains undervalued [42] Question: Have there been changes in consumer behavior by income or age cohort? - Management observed growth in higher-income guests while other income categories remained stable, attributing this to product innovation and marketing efforts [46] Question: What is the expected EBIT loss for company operations in 2026? - Management expects the company restaurant portfolio to break even in 2026, following a negative $10 million EBITDA in 2025 [73]

Core Insights - CVS Health's Health Care Delivery business has shown strong revenue growth, with a 27% increase in Q1 2025, driven by strategic acquisitions and a focus on value-based care [1][8] Group 1: Financial Performance - The Health Care Delivery segment's revenue growth of 27% in Q1 2025 excludes the impact of exiting certain programs and selling parts of the business [1] - Integration costs related to the acquisitions of Signify Health and Oak Street Health amounted to $45 million in Q1 2025 [2] - CVS Health's Signify unit completed over 3 million in-home health evaluations in 2024, while Oak Street reported a 37% increase in at-risk members [3][8] Group 2: Market Dynamics - The financial performance of the Health Care Delivery business is closely linked to Medicare Advantage medical cost trends, with early signs of pressure observed at Oak Street Health [4] - Humana's CenterWell segment reported a 37.5% revenue growth in Q1 2025, driven by primary care business expansion [5] - Agilon Health is transforming senior healthcare with its PalliUM program, which has seen increased patient participation [6] Group 3: Valuation and Estimates - CVS Health shares have increased by 6.2% over the past six months, contrasting with an 11.6% decline in the industry [7] - The stock is trading at a forward price-to-earnings ratio of 9.06, below the industry average of 14.37, and carries a Value Score of A [9] - Consensus estimates for CVS Health's 2025 earnings have shown an upward trend, with current estimates for Q1 2025 at $1.47 and for the full year at $6.12 [10][11]